Head-to-head dispatch
Alan Meds vs Somi Health
Two GLP-1 providers, one scorecard. Both are graded on the same six Desk Score dimensions — here is how they stack up, and which one fits you.
Desk Score
Telehealth platform offering compounded semaglutide and tirzepatide with multiple administration formats including microdosing and oral options.
$158/mo (compounded) sema · $295/mo (compounded) tirz · Verified July 20, 2026
Marked down on: Limited public information on program details
FDAWarning letter issued to Alan Health Technologies Inc. dba Alan in February 2026. See the FDA warning-letter database.
Desk Score
Somi Health is a telehealth weight-loss provider offering compounded GLP-1 medications - compounded semaglutide and tirzepatide injections plus an oral semaglutide tablet.
$135/mo (starting dose, compounded) sema · $165/mo (starting dose, compounded) tirz · Verified June 19, 2026
Marked down on: Compounded only - no brand-name Wegovy, Zepbound, Ozempic or Mounjaro
Alan Meds takes this head-to-head with the higher Desk Score, 77/100 (C+) against 64/100 (C) for Somi Health. Somi Health still holds its ground where its strengths line up with yours.
Desk Score, dimension by dimension
Same six measured dimensions for both. The red flag marks the stronger side. See the methodology.
Alan Meds
77/100
C+
Somi Health
64/100
C
Price transparency
State access
Molecule range
Onboarding speed
Support responsiveness
Licensing & trust
The spec sheet
| Field | Alan Meds | Somi Health |
|---|---|---|
| Semaglutide | $158/mo (compounded) | $135/mo (starting dose, compounded) |
| Tirzepatide | $295/mo (compounded) | $165/mo (starting dose, compounded) |
| Coverage | 46 states | Not listed on Somi Health's site (checked June 19, 2026) |
| Brand-name | Compounded only | Compounded only |
| Oral option | Yes | Yes |
| Best for | Budget-conscious shoppers. | Low-cost compounded semaglutide or tirzepatide, plus an oral no-needle option. |
| Desk Score | 77/100C+ | 64/100C |
The verdict
Desk pick — Alan MedsAlan Meds takes this head-to-head with the higher Desk Score, 77/100 (C+) against 64/100 (C) for Somi Health. Somi Health still holds its ground where its strengths line up with yours.
Choose Alan Meds if…
Budget-conscious shoppers.
$158/mo (compounded) sema · $295/mo (compounded) tirz · 46 states
FDAWarning letter issued to Alan Health Technologies Inc. dba Alan in February 2026. See the FDA warning-letter database.
Choose Somi Health if…
Low-cost compounded semaglutide or tirzepatide, plus an oral no-needle option.
$135/mo (starting dose, compounded) sema · $165/mo (starting dose, compounded) tirz
Assume any provider we list may compensate us — we may earn a referral commission at no extra cost to you, and what we file on a provider reads the same either way. Read full breakdowns: Alan Meds · Somi Health.
Also here
CoreAge Rx tops every dispatch at 94/100
Whichever of these two you lean toward, the Desk's #1-rated provider outscores them both. The Desk's top dispatch: one price at every dose, both molecules, all 50 states — but the $99 and $149 figures are 12-month plans paid up front, not a monthly bill.
More head-to-heads
- Alan Meds vs CoreAge Rx
- CoreAge Rx vs Somi Health
- Alan Meds vs Strut Health
- Somi Health vs Strut Health
- Alan Meds vs Zera Health
- Somi Health vs Zera Health
Or see the full comparison hub and the complete ranking.
Pricing and verification reflect each provider's public disclosures at last scoring; the Desk Score is our editorial judgment per the methodology. Prices change — confirm on each provider's own site. Not medical advice; see our disclosure.